MedTrace Logo

Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs

NCT04590300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2024-06-18

No results posted yet for this study

Summary

People with schizophrenia and bipolar disorder display alterations in cognition and metacognition. These alterations may have an impact on learning during therapeutic education programs.

Conditions

Interventions

OTHER

QUESTIONNAIRES

1 questionnaire at the beginning of the study, before FTE program 1 questionnaire at the end of FTE

Sponsors & Collaborators

  • Centre Hospitalier Charles Perrens, Bordeaux

    lead OTHER_GOV

Principal Investigators

  • Clelia QUILES, MD · CH Charles Perrens

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2022-09-01
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590300 on ClinicalTrials.gov